Solventum Corporation (SOLV) EV/Assets Ratio: 1.31x
Is Solventum Corporation’s EV/Assets ratio high or low?
Solventum Corporation's EV/Assets ratio of 1.31x is in line with its 2-year average of 1.28x, around the middle of its 2-year range (1.06x–1.49x).
As of Friday, June 12, 2026. 3.25% above its 12-month average of 1.27x.
SOLV EV/Assets Ratio Chart
SOLV Average EV/Assets Ratio Chart
SOLV Current vs Average EV/Assets Ratio Chart
SOLV EV/Assets Ratio Metrics
EV/ASSETS RATIO
1.31x
EV/ASSETS RATIO AVG TTM
1.27x
EV/ASSETS RATIO AVG 3Y
1.28x
EV/ASSETS RATIO AVG 5Y
1.28x
EV/ASSETS RATIO AVG 10Y
1.28x
EV/ASSETS RATIO AVG 15Y
1.28x
EV/ASSETS RATIO AVG 20Y
1.28x
CURRENT VS TTM AVG
+3.25%
CURRENT VS 3Y AVG
+2.01%
CURRENT VS 5Y AVG
+2.01%
CURRENT VS 10Y AVG
+2.01%
CURRENT VS 15Y AVG
+2.01%
CURRENT VS 20Y AVG
+2.01%
SOLV Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 1.31x | 1.27x | 1.28x | 1.28x |
| Align Technology, Inc. (ALGN) | $12.64B | 1.85x | 1.75x | 2.56x | 3.76x |
| Baxter International Inc. (BAX) | $10.58B | 0.92x | 0.91x | 1.05x | 1.32x |
| Hologic, Inc. (HOLX) | $16.97B | 1.91x | 1.84x | 1.98x | 2.08x |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 1.56x | 1.50x | 1.60x | 1.95x |
| Tempus AI, Inc. (TEM) | $8.65B | 4.29x | 6.24x | 7.86x | 7.86x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 0.89x | 0.88x | 0.89x | 0.99x |
| Moderna, Inc. (MRNA) | $19.70B | 1.65x | 1.14x | 1.48x | 2.53x |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 3.20x | 5.94x | 7.31x | 5.78x |
| BioNTech SE (BNTX) | $22.39B | 0.44x | 0.55x | 0.54x | 1.39x |
Solventum Corporation EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Solventum Corporation (SOLV)?
- The EV/Assets ratio for SOLV stock is 1.31x.
- Is Solventum Corporation's EV/Assets ratio high or low?
- Solventum Corporation's EV/Assets ratio of 1.31x is in line with its 2-year average of 1.28x, around the middle of its 2-year range (1.06x–1.49x).
- What is the TTM average EV/Assets ratio for Solventum Corporation (SOLV)?
- The TTM average EV/Assets ratio for SOLV stock is 1.27x.
- What is the 3Y average EV/Assets ratio for Solventum Corporation (SOLV)?
- The 3Y average EV/Assets ratio for SOLV stock is 1.28x.
- What is the 5Y average EV/Assets ratio for Solventum Corporation (SOLV)?
- The 5Y average EV/Assets ratio for SOLV stock is 1.28x.
- What is the 10Y average EV/Assets ratio for Solventum Corporation (SOLV)?
- The 10Y average EV/Assets ratio for SOLV stock is 1.28x.
- What is the 15Y average EV/Assets ratio for Solventum Corporation (SOLV)?
- The 15Y average EV/Assets ratio for SOLV stock is 1.28x.
- What is the 20Y average EV/Assets ratio for Solventum Corporation (SOLV)?
- The 20Y average EV/Assets ratio for SOLV stock is 1.28x.
Solventum Corporation EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-11 | 1.31x |
| 2026-06-10 | 1.33x |
| 2026-06-09 | 1.35x |
| 2026-06-08 | 1.30x |
| 2026-06-05 | 1.33x |
| 2026-06-04 | 1.35x |
| 2026-06-03 | 1.30x |
| 2026-06-02 | 1.27x |
| 2026-06-01 | 1.26x |
| 2026-05-29 | 1.25x |
| 2026-05-28 | 1.27x |
| 2026-05-27 | 1.27x |
| 2026-05-26 | 1.27x |
| 2026-05-22 | 1.28x |
| 2026-05-21 | 1.28x |
| 2026-05-20 | 1.27x |
| 2026-05-19 | 1.25x |
| 2026-05-18 | 1.27x |
| 2026-05-15 | 1.25x |
| 2026-05-14 | 1.25x |
| 2026-05-13 | 1.25x |
| 2026-05-12 | 1.26x |
| 2026-05-11 | 1.24x |
| 2026-05-08 | 1.23x |
| 2026-05-07 | 1.21x |
| 2026-05-06 | 1.20x |
| 2026-05-05 | 1.18x |
| 2026-05-04 | 1.12x |
| 2026-05-01 | 1.11x |
| 2026-04-30 | 1.12x |
| 2026-04-29 | 1.11x |
| 2026-04-28 | 1.12x |
| 2026-04-27 | 1.15x |
| 2026-04-24 | 1.13x |
| 2026-04-23 | 1.14x |
| 2026-04-22 | 1.14x |
| 2026-04-21 | 1.14x |
| 2026-04-20 | 1.15x |
| 2026-04-17 | 1.16x |
| 2026-04-16 | 1.14x |
| 2026-04-15 | 1.14x |
| 2026-04-14 | 1.14x |
| 2026-04-13 | 1.12x |
| 2026-04-10 | 1.10x |
| 2026-04-09 | 1.10x |
| 2026-04-08 | 1.09x |
| 2026-04-07 | 1.06x |
| 2026-04-06 | 1.07x |
| 2026-04-02 | 1.07x |
| 2026-04-01 | 1.08x |
| 2026-03-31 | 1.09x |
| 2026-03-30 | 1.07x |
| 2026-03-27 | 1.06x |
| 2026-03-26 | 1.08x |
| 2026-03-25 | 1.08x |
| 2026-03-24 | 1.08x |
| 2026-03-23 | 1.10x |
| 2026-03-20 | 1.10x |
| 2026-03-19 | 1.11x |
| 2026-03-18 | 1.11x |
| 2026-03-17 | 1.13x |
| 2026-03-16 | 1.11x |
| 2026-03-13 | 1.11x |
| 2026-03-12 | 1.10x |
| 2026-03-11 | 1.12x |
| 2026-03-10 | 1.12x |
| 2026-03-09 | 1.13x |
| 2026-03-06 | 1.14x |
| 2026-03-05 | 1.16x |
| 2026-03-04 | 1.15x |
| 2026-03-03 | 1.16x |
| 2026-03-02 | 1.19x |
| 2026-02-27 | 1.20x |
| 2026-02-26 | 1.22x |
| 2026-02-25 | 1.19x |
| 2026-02-24 | 1.17x |
| 2026-02-23 | 1.16x |
| 2026-02-20 | 1.17x |
| 2026-02-19 | 1.17x |
| 2026-02-18 | 1.19x |
| 2026-02-17 | 1.18x |
| 2026-02-13 | 1.20x |
| 2026-02-12 | 1.20x |
| 2026-02-11 | 1.27x |
| 2026-02-10 | 1.26x |
| 2026-02-09 | 1.23x |
| 2026-02-06 | 1.23x |
| 2026-02-05 | 1.22x |
| 2026-02-04 | 1.21x |
| 2026-02-03 | 1.20x |
| 2026-02-02 | 1.22x |
| 2026-01-30 | 1.22x |
| 2026-01-29 | 1.21x |
| 2026-01-28 | 1.21x |
| 2026-01-27 | 1.22x |
| 2026-01-26 | 1.24x |
| 2026-01-23 | 1.24x |
| 2026-01-22 | 1.26x |
| 2026-01-21 | 1.26x |
| 2026-01-20 | 1.24x |
| 2026-01-16 | 1.25x |
| 2026-01-15 | 1.26x |
| 2026-01-14 | 1.25x |
| 2026-01-13 | 1.25x |
| 2026-01-12 | 1.33x |
| 2026-01-09 | 1.33x |
| 2026-01-08 | 1.33x |
| 2026-01-07 | 1.31x |
| 2026-01-06 | 1.29x |
| 2026-01-05 | 1.26x |
| 2026-01-02 | 1.24x |
| 2025-12-31 | 1.24x |
| 2025-12-30 | 1.26x |
| 2025-12-29 | 1.26x |
| 2025-12-26 | 1.26x |
| 2025-12-24 | 1.26x |
| 2025-12-23 | 1.26x |
| 2025-12-22 | 1.26x |
| 2025-12-19 | 1.27x |
| 2025-12-18 | 1.26x |
| 2025-12-17 | 1.25x |
| 2025-12-16 | 1.26x |
| 2025-12-15 | 1.28x |
| 2025-12-12 | 1.29x |
| 2025-12-11 | 1.29x |
| 2025-12-10 | 1.28x |
| 2025-12-09 | 1.26x |
| 2025-12-08 | 1.29x |
| 2025-12-05 | 1.32x |
| 2025-12-04 | 1.32x |
| 2025-12-03 | 1.32x |
| 2025-12-02 | 1.32x |
| 2025-12-01 | 1.32x |
| 2025-11-28 | 1.32x |
| 2025-11-26 | 1.32x |
| 2025-11-25 | 1.33x |
| 2025-11-24 | 1.30x |
| 2025-11-21 | 1.29x |
| 2025-11-20 | 1.25x |
| 2025-11-19 | 1.22x |
| 2025-11-18 | 1.22x |
| 2025-11-17 | 1.21x |
| 2025-11-14 | 1.20x |
| 2025-11-13 | 1.19x |
| 2025-11-12 | 1.18x |
| 2025-11-11 | 1.18x |
| 2025-11-10 | 1.15x |
| 2025-11-07 | 1.15x |
| 2025-11-06 | 1.08x |
| 2025-11-05 | 1.27x |
| 2025-11-04 | 1.28x |
| 2025-11-03 | 1.28x |
| 2025-10-31 | 1.29x |
| 2025-10-30 | 1.29x |
| 2025-10-29 | 1.30x |
| 2025-10-28 | 1.31x |
| 2025-10-27 | 1.32x |
| 2025-10-24 | 1.32x |
| 2025-10-23 | 1.33x |
| 2025-10-22 | 1.33x |
| 2025-10-21 | 1.33x |
| 2025-10-20 | 1.33x |
| 2025-10-17 | 1.32x |
| 2025-10-16 | 1.32x |
| 2025-10-15 | 1.32x |
| 2025-10-14 | 1.32x |
| 2025-10-13 | 1.31x |
| 2025-10-10 | 1.31x |
| 2025-10-09 | 1.32x |
| 2025-10-08 | 1.33x |
| 2025-10-07 | 1.32x |
| 2025-10-06 | 1.34x |
| 2025-10-03 | 1.35x |
| 2025-10-02 | 1.35x |
| 2025-10-01 | 1.33x |
| 2025-09-30 | 1.33x |
| 2025-09-29 | 1.33x |
| 2025-09-26 | 1.32x |
| 2025-09-25 | 1.30x |
| 2025-09-24 | 1.32x |
| 2025-09-23 | 1.34x |
| 2025-09-22 | 1.34x |
| 2025-09-19 | 1.34x |
| 2025-09-18 | 1.35x |
| 2025-09-17 | 1.35x |
| 2025-09-16 | 1.35x |
| 2025-09-15 | 1.34x |
| 2025-09-12 | 1.34x |
| 2025-09-11 | 1.34x |
| 2025-09-10 | 1.31x |
| 2025-09-09 | 1.33x |
| 2025-09-08 | 1.35x |
| 2025-09-05 | 1.33x |
| 2025-09-04 | 1.33x |
| 2025-09-03 | 1.32x |
| 2025-09-02 | 1.32x |
| 2025-08-29 | 1.34x |
| 2025-08-28 | 1.33x |
| 2025-08-27 | 1.33x |
| 2025-08-26 | 1.33x |
| 2025-08-25 | 1.33x |
| 2025-08-22 | 1.34x |
| 2025-08-21 | 1.32x |
| 2025-08-20 | 1.33x |
| 2025-08-19 | 1.33x |
| 2025-08-18 | 1.31x |
| 2025-08-15 | 1.32x |
| 2025-08-14 | 1.34x |
| 2025-08-13 | 1.35x |
| 2025-08-12 | 1.32x |
| 2025-08-11 | 1.32x |
| 2025-08-08 | 1.34x |
| 2025-08-07 | 1.32x |
| 2025-08-06 | 1.38x |
| 2025-08-05 | 1.38x |
| 2025-08-04 | 1.39x |
| 2025-08-01 | 1.37x |
| 2025-07-31 | 1.37x |
| 2025-07-30 | 1.39x |
| 2025-07-29 | 1.39x |
| 2025-07-28 | 1.40x |
| 2025-07-25 | 1.41x |
| 2025-07-24 | 1.40x |
| 2025-07-23 | 1.40x |
| 2025-07-22 | 1.39x |
| 2025-07-21 | 1.38x |
| 2025-07-18 | 1.39x |
| 2025-07-17 | 1.40x |
| 2025-07-16 | 1.39x |
| 2025-07-15 | 1.39x |
| 2025-07-14 | 1.40x |
| 2025-07-11 | 1.40x |
| 2025-07-10 | 1.42x |
| 2025-07-09 | 1.40x |
| 2025-07-08 | 1.41x |
| 2025-07-07 | 1.43x |
| 2025-07-03 | 1.45x |
| 2025-07-02 | 1.45x |
| 2025-07-01 | 1.45x |
| 2025-06-30 | 1.42x |
| 2025-06-27 | 1.42x |
| 2025-06-26 | 1.41x |
| 2025-06-25 | 1.41x |
| 2025-06-24 | 1.41x |
| 2025-06-23 | 1.39x |
| 2025-06-20 | 1.39x |
| 2025-06-18 | 1.38x |
| 2025-06-17 | 1.38x |
| 2025-06-16 | 1.40x |
| 2025-06-13 | 1.40x |
| 2025-06-12 | 1.40x |
| 2025-06-11 | 1.40x |
| 2025-06-10 | 1.42x |
| 2025-06-09 | 1.41x |
| 2025-06-06 | 1.41x |
| 2025-06-05 | 1.41x |
| 2025-06-04 | 1.41x |
| 2025-06-03 | 1.40x |
| 2025-06-02 | 1.39x |
| 2025-05-30 | 1.39x |
Showing the most recent 260 of 523 data points. The chart above shows the full history.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson